Table 3.

Univariate analysis of the predictors of self-reported infection

Variable	OR (95% CI)	p value
Age	0.97 (0.95–1.00)	0.06
Gender, female	1.85 (0.96–3.65)	0.07
Disease duration	0.98 (0.94–1.02)	0.36
Number of ocrelizumab doses	0.91 (0.72–1.14)	0.41
EDSS	0.92 (0.78–1.08)	0.30
Prior immunosuppression	1.63 (0.83–3.17)	0.15
Lymphocyte count	1.37 (0.88–2.13)	0.17
Neutrophil count	1.10 (0.93–1.29)	0.28
IgG level	0.89 (0.77–1.04)	0.15
IgA level	0.44 (0.25–0.76)	0.004
IgM level	0.62 (0.26–1.49)	0.29
CD4+	1.42 (0.52–3.89)	0.49
CD8+	0.36 (0.06–2.31)	0.28
CD19+	3.01 (0.00–4986.26)	0.77

Self-reported infection included any patient that reported at least one infection or more. Bold values indicate statistical significance

CI confidence intervals, EDSS Expanded Disability Status Scale, OR odds ratio